Journal of Clinical Review & Case Reports(JCRC)
ISSN: 2573-9565 | DOI: 10.33140/JCRC
Impact Factor: 1.823
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Radical benefits and harms associated with immune checkpoint inhibitor therapy in cancer and the true mechanisms behind
Citation
Kangla Tsung, Zhang Xu, Zhanghui and Tanlun Research Participants Group
Kangla Tsung, Zhang Xu, Zhanghui and Tanlun Research Participants Group (2022) Radical benefits and harms associated with immune checkpoint inhibiting therapy in cancer and the true mechanisms behind. Journal of Clinical Review & Case Reports 7(3):19-27.